An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice.

The response of cardiomyocytes to biomechanical stress can determine the pathophysiology of hypertrophic cardiac disease, and targeting the pathways regulating these responses is a therapeutic goal. However, little is known about how biomechanical stress is sensed by the cardiomyocyte sarcomere to transduce intracellular hypertrophic signals or how the dysfunction of these pathways may lead to disease. Here, we found that four-and-a-half LIM domains 1 (FHL1) is part of a complex within the cardiomyocyte sarcomere that senses the biomechanical stress-induced responses important for cardiac hypertrophy. Mice lacking Fhl1 displayed a blunted hypertrophic response and a beneficial functional response to pressure overload induced by transverse aortic constriction. A link to the Galphaq (Gq) signaling pathway was also observed, as Fhl1 deficiency prevented the cardiomyopathy observed in Gq transgenic mice. Mechanistic studies demonstrated that FHL1 plays an important role in the mechanism of pathological hypertrophy by sensing biomechanical stress responses via the N2B stretch sensor domain of titin and initiating changes in the titin- and MAPK-mediated responses important for sarcomere extensibility and intracellular signaling. These studies shed light on the physiological regulation of the sarcomere in response to hypertrophic stress.

[1]  Wolfgang A Linke,et al.  Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. , 2007, Cardiovascular research.

[2]  S. Meloche,et al.  Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo , 2007, Proceedings of the National Academy of Sciences.

[3]  M. Therrien,et al.  KSR and CNK: two scaffolds regulating RAS-mediated RAF activation , 2007, Oncogene.

[4]  Susan S. Brown,et al.  FHL3 binds MyoD and negatively regulates myotube formation , 2007, Journal of Cell Science.

[5]  Yiming Wu,et al.  Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy , 2007, Proceedings of the National Academy of Sciences.

[6]  Yiming Wu,et al.  Cardiac titin: structure, functions and role in disease. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[7]  D. Sacks The role of scaffold proteins in MEK/ERK signalling. , 2006, Biochemical Society transactions.

[8]  Yusu Gu,et al.  &agr;-E-Catenin Inactivation Disrupts the Cardiomyocyte Adherens Junction, Resulting in Cardiomyopathy and Susceptibility to Wall Rupture , 2006, Circulation.

[9]  T. Arimura,et al.  Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy , 2006, Journal of Muscle Research & Cell Motility.

[10]  U. Moens,et al.  The multifunctional roles of the four-and-a-half-LIM only protein FHL2 , 2006, Cellular and Molecular Life Sciences CMLS.

[11]  W. Kolch Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[12]  Masahiko Hoshijima,et al.  Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy. , 2005, Journal of molecular and cellular cardiology.

[13]  E. Olson,et al.  Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress , 2004, Nature Medicine.

[14]  Cinzia Perrino,et al.  Network integration of the adrenergic system in cardiac hypertrophy. , 2004, Cardiovascular research.

[15]  Anthony J. Muslin,et al.  Raf-1 Kinase Is Required for Cardiac Hypertrophy and Cardiomyocyte Survival in Response to Pressure Overload , 2004, Circulation.

[16]  Peipei Ping,et al.  Scaffold proteins and assembly of multiprotein signaling complexes. , 2004, Journal of molecular and cellular cardiology.

[17]  Qiang Zhou,et al.  A Cypher/ZASP Mutation Associated with Dilated Cardiomyopathy Alters the Binding Affinity to Protein Kinase C* , 2004, Journal of Biological Chemistry.

[18]  R. Schüle,et al.  Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in Cardiomyocytes , 2004, Molecular and Cellular Biology.

[19]  S. Liggett,et al.  Common Genomic Response in Different Mouse Models of &bgr;-Adrenergic–Induced Cardiomyopathy , 2003, Circulation.

[20]  G. Valle,et al.  Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.

[21]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[22]  R. Dietz,et al.  Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy , 2003, Circulation.

[23]  Luigi Fratta,et al.  Melusin, a muscle-specific integrin β1–interacting protein, is required to prevent cardiac failure in response to chronic pressure overload , 2003, Nature Medicine.

[24]  Masahiko Hoshijima,et al.  The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy , 2002, Cell.

[25]  Daniel Auerbach,et al.  Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2 , 2002, Journal of Cell Science.

[26]  G. Esposito,et al.  Cardiac hypertrophy: role of G protein-coupled receptors. , 2002, Journal of cardiac failure.

[27]  J. Molkentin,et al.  Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. , 2002, Circulation research.

[28]  N. Traficante,et al.  Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-α signaling , 2002, Nature Structural Biology.

[29]  J. Ross,et al.  Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. , 2001, The Journal of clinical investigation.

[30]  Qiang Zhou,et al.  Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy , 2001, The Journal of cell biology.

[31]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes , 2001, Nature Medicine.

[32]  A. Marian,et al.  Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. , 2001, Journal of the American College of Cardiology.

[33]  J. Ross,et al.  Adult mice deficient in actinin–associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy , 2001, Nature Medicine.

[34]  W. Koch,et al.  Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload , 2001, Circulation.

[35]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. , 2001, Nature medicine.

[36]  R. Kitsis,et al.  The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.

[37]  H. Granzier,et al.  Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. , 2000, Journal of molecular and cellular cardiology.

[38]  J. Ross,et al.  FHL2 (SLIM3) Is Not Essential for Cardiac Development and Function , 2000, Molecular and Cellular Biology.

[39]  Qiang Zhou,et al.  Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system , 2000, Mechanisms of Development.

[40]  C. Lee,et al.  Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. , 2000, Genomics.

[41]  H. Granzier,et al.  Molecular dissection of N2B cardiac titin's extensibility. , 1999, Biophysical journal.

[42]  Wolfgang A. Linke,et al.  I-Band Titin in Cardiac Muscle Is a Three-Element Molecular Spring and Is Critical for Maintaining Thin Filament Structure , 1999, The Journal of cell biology.

[43]  G. Dorn,et al.  Gq signaling in cardiac adaptation and maladaptation. , 1999, Trends in cardiovascular medicine.

[44]  John W. Adams,et al.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Waye,et al.  Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1). , 1998, Gene.

[46]  K P Fung,et al.  A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. , 1997, Circulation.

[47]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[48]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[49]  G. Dorn,et al.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Hewett,et al.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. , 1996, The Journal of clinical investigation.

[51]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[52]  M. Zerial,et al.  Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion , 1995, Cell.

[53]  Siegfried Labeit,et al.  Titins: Giant Proteins in Charge of Muscle Ultrastructure and Elasticity , 1995, Science.

[54]  P. Shaw,et al.  Activation of ternary complex factor Elk-1 by stress-activated protein kinases , 1995, Current Biology.

[55]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[56]  J. Ross,et al.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Chien,et al.  Erratum: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy (Proc. Natl. Acad. Sci. USA (September 1991) 88 (8277-8281)) , 1991 .